p-Hydroxycinnamic Acid Market Analysis

In p-hydroxycinnamic acid market, chemical industry segment is projected to capture revenue share of over 32.69% by 2036, up from a revenue of USD 53.7 Million in the year 2021. However, the pharmaceutical industry segment is estimated to grow with a highest CAGR of 4.4% over the forecast period, backed by extensive use of p-hydroxycinnamic acid in medical application. Most of the mouth washers and toothpaste also content this acid. Further it is also being used for treating cancer, and cardiovascular disease. Increasing cases of diabetes is moreover expected to boost the growth of the market. There were 1.4 million new cases of diabetes identified in 2019. It is estimated that, over 37.3 million Americans, or one in ten, have diabetes.

Our in-depth analysis of the global p-hydroxycinnamic acid market includes the following segments:

By Product	Purity Modified p-Conmaric Acid
By End-User	Chemical Industry Food Industry Cosmetic Industry Pharmaceutical Industry

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of p-hydroxycinnamic acid is estimated at USD 149.34 million.

p-Hydroxycinnamic Acid Market size was valued at USD 144.6 million in 2023 and is set to exceed USD 243.8 million by 2036, registering over 4.1% CAGR during the forecast period i.e., between 2024-2036. The market growth is impelled by growing prevalence of obesity and diabetes, technology advancement in p-hydroxycinnamic acid, growing cosmetic industry, and others.

Asia Pacific industry is expected to dominate 43% revenue share by 2036, attributed to growing middle-class population in this region.

The major players in the market are Cayman Chemical, United States Biological Corporation Inc, Tokyo Chemical Industry Co., Ltd., AdooQ BioScience, and more.

p-Hydroxycinnamic Acid Market Analysis